TCA
NKGNW
Taconic Capital Advisors’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-69,942
| Closed | -$6.99K | – | 73 |
|
|
2024
Q4 | $6.99K | Hold |
69,942
| – | – | ﹤0.01% | 54 |
|
|
2024
Q3 | $4.95K | Hold |
69,942
| – | – | ﹤0.01% | 66 |
|
|
2024
Q2 | $6.92K | Sell |
69,942
-58
| -0.1% | -$6 | ﹤0.01% | 72 |
|
|
2024
Q1 | $11.2K | Hold |
70,000
| – | – | ﹤0.01% | 68 |
|
|
2023
Q4 | $4.95K | Hold |
70,000
| – | – | ﹤0.01% | 104 |
|
|
2023
Q3 | $27.6K | Hold |
70,000
| – | – | ﹤0.01% | 78 |
|
|
2023
Q2 | $14K | Hold |
70,000
| – | – | ﹤0.01% | 157 |
|
|
2023
Q1 | $9.81K | Hold |
70,000
| – | – | ﹤0.01% | 244 |
|
|
2022
Q4 | $5.94K | Hold |
70,000
| – | – | ﹤0.01% | 444 |
|
|
2022
Q3 | $11K | Hold |
70,000
| – | – | ﹤0.01% | 563 |
|
|
2022
Q2 | $18K | Hold |
70,000
| – | – | ﹤0.01% | 590 |
|
|
2022
Q1 | $42K | Hold |
70,000
| – | – | ﹤0.01% | 572 |
|
|
2021
Q4 | $81K | Hold |
70,000
| – | – | ﹤0.01% | 460 |
|
|
2021
Q3 | $81K | Buy |
+70,000
| New | +$81K | ﹤0.01% | 386 |
|